Johnson & Johnson – https://istanbulpost.com.tr

Shares of Johnson & Johnson Rose 1.3%

25 February 2021
by EDITORIAL DESK
Comments Off on Shares of Johnson & Johnson Rose 1.3%

Johnson & Johnson shares were up 1.3 percent. They were responding to an assessment by the US Food and Drug Administration, according to which the pharmaceutical company’s corona vaccine, which…

FDA, J&J Vaccine Imminent Approval “Safe And Effective”

25 February 2021
by EDITORIAL DESK
Comments Off on FDA, J&J Vaccine Imminent Approval “Safe And Effective”

The US Food and Drug Administration (FDA) acknowledged the preventive effect and safety of the Johnson & Johnson (J&J) Covid- 19 vaccine on the 24th Johnson & Johnson requested the…

Johnson & Johnson Corona 19 Aşı Onayı İçin Başvurdu

05 February 2021
by EDITORIAL DESK
Comments Off on Johnson & Johnson Corona 19 Aşı Onayı İçin Başvurdu

Johnson & Johnson, 4’te şirketin bağlı kuruluşu Janssen Biotech‘in bir kez uygulanan “Corona 19” aşı adayı için FDA’ya “Acil Kullanım Onayı” (EUA) başvurusunda bulunduğunu duyurdu. “Acil kullanım onayı” başvurusu, 3….

Johnson & Johnson Covid-19 Vaccine Trial Interrupted due to Sick Participant

13 October 2020
by EDITORIAL DESK
Comments Off on Johnson & Johnson Covid-19 Vaccine Trial Interrupted due to Sick Participant

The pharmaceutical group Johnson & Johnson announced on Monday the suspension of its clinical trial of a vaccine against Covid-19, one of the participants having fallen ill. “We have temporarily…

Vaccine: Johnson & Johnson” Stimulates A Strong Immune Response to Prevent Corona

26 September 2020
by EDITORIAL DESK
Comments Off on Vaccine: Johnson & Johnson” Stimulates A Strong Immune Response to Prevent Corona

Provisional results, published Friday, showed that a single dose of an experimental Covid-19 vaccine stimulated a strong immune response to prevent the disease in an early to medium-stage clinical trial….

Johnson & Johnson: “2021 Nisan Ayında 600-800 Milyon Koronavirüs Aşısı Hazır”

16 April 2020
by EDITORIAL DESK
Comments Off on Johnson & Johnson: “2021 Nisan Ayında 600-800 Milyon Koronavirüs Aşısı Hazır”

Johnson & Johnson (J & J), klinik çalışma başarılı olursa, önümüzdeki yıl Nisan ayına kadar 900 milyon doz koronavirüs (Corona 19) aşısı üretebileceğini açıkladı. Firma Eylül ayında yapılması planlanan klinik…

Johnson & Johnson will Have 600-900 Million Coronavirus Vaccines by 2021

16 April 2020
by EDITORIAL DESK
Comments Off on Johnson & Johnson will Have 600-900 Million Coronavirus Vaccines by 2021

Johnson & Johnson (J & J) predicts that if the clinical trial is successful, it will be able to produce 900 million doses of new coronavirus (Corona 19) vaccine by…

Koronavirus Aşısı Bulundu Değeri 1 Milyar Dolar

02 April 2020
by EDITORIAL DESK
Comments Off on Koronavirus Aşısı Bulundu Değeri 1 Milyar Dolar

Hülya Karahan: Production Editor istanbulpostcomtr@gmail.com Johnson & Johnson (J&J) şirketi, klinik öncesi araştırmaların ardından COVID-19 aşısı için aday gösterildiğini açıkladı. Birden fazla akademik kurumdaki bilim insanlarıyla yapılan işbirlikleri sayesinde, J&J’nin…

Page 1 of 1